From an outcome database, untreated patients with an NIHSS score of 5 or less presenting within a 4.5-hour window were identified and 3-month modified Rankin Scale (mRS) outcomes were analyzed according to individual isolated symptoms and total NIHSS scores. The validity of the following minor stroke definitions were assessed: (1) the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator (NINDS-TPA) trials' definition, (2) the total NIHSS score, varying a cutoff point from 0 to 4, and (3) our proposed definition that included an NIHSS score?=?0 or an NIHSS score?=?1 on the items of level of consciousness (LOC), gaze, facial palsy, sensory, or dysarthria.
Of 647 patients, 172 patients (26.6 % ) had a 3-month unfavorable outcome (mRS score 2-6). Favorable outcome was achieved in more than 80 % of patients with an NIHSS score of 1 or less or with an isolated symptom on the LOC, gaze, facial palsy, sensory, or dysarthria item. In contrast, unfavorable outcome proportion was more than 25 % in patients with an NIHSS score of 2 or more. When the NINDS-TPA trials' definition, our definition, or the definition of an NIHSS score of 1 or less were applied, more than 75 % of patients with an unfavorable outcome were defined as a non-minor stroke and less than 15 % of patients with an unfavorable outcome were defined?as a minor stroke.
Implementation of an optimal definition of minor?stroke into thrombolysis decision-making process would decrease the unfavorable outcomes in patients with low NIHSS scores.